Progressive Multifocal Leukoencephalopathy

Progressive Multifocal Leukoencephalopathy (PML) is a progressive demyelinating disease of the CNS caused by JC polyoma virus (JCV) reactivation. It emerges in individuals with impaired cell-mediated immunity. This feed follows research into this disease.

December 3, 2021

Progressive Multifocal Leukoencephalopathy in immunocompetent patient: a case report and review of literature.

Journal of Medical Virology
Shitiz SriwastavaParissa Feizi
December 3, 2021

Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy.

Emerging Infectious Diseases
Nicolas LambertPierre Maquet
December 1, 2021
Open Access

FMRP and MOV10 regulate Dicer1 expression and dendrite development.

PloS One
Monica C LannomStephanie Ceman
November 29, 2021
Case Report

A 50 Year-Old Woman with A Delayed Diagnosis of Neuromyelitis Optica Spectrum Disorder: The Clinical Course and Serial Neuroimaging Findings.

Acta Neurologica Taiwanica
Yu-Ju Huang, Wen-Neng Chang
November 28, 2021
Open Access

PI3K/AKT/mTOR Signaling Pathway Is Required for JCPyV Infection in Primary Astrocytes.

Michael P WilczekMelissa S Maginnis
November 27, 2021

Progressive multifocal leukoencephalopathy in the era of chimeric antigen receptor T-cell therapy.

The Lancet. Haematology
Strachan MackenzieClaire Roddie
November 23, 2021
Case Report

Progressive Multifocal Leukoencephalopathy After Chimeric Antigen Receptor T-Cell Therapy for Recurrent Non-Hodgkin Lymphoma.

Journal of Hematology
Jared T AhrendsenDavid Avigan
November 20, 2021

The devil's details: pathological correlates of progressive multifocal leukoencephalopathy magnetic resonance imaging.

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
David B Clifford
November 20, 2021

Polyomavirus exerts detrimental effects on renal function in patients after lung transplantation.

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
Dieter MunkerClaus Neurohr
November 19, 2021

[Progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis under salazosulfapyridine treatment].

Rinshō shinkeigaku = Clinical neurology
Tomoko OkazakiTakehiko Yanagihara
November 19, 2021

The neuroradiology of progressive multifocal leukoencephalopathy: a clinical trial perspective.

Brain : a Journal of Neurology
Laura E BaldassariNancy Richert
November 18, 2021

Off the Shelf Third Party Virus Specific T-Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplant Recipients.

Transplantation and Cellular Therapy
Jeremy D RubinsteinAdam S Nelson
November 16, 2021

Podophyllotoxin-combined 5-aminolevulinic acid photodynamic therapy significantly promotes HR-HPV-infected cell death.

Photodermatology, Photoimmunology & Photomedicine
Jingying WangChangxing Li
November 15, 2021
Case Report
Open Access

Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal.

Frontiers in Neurology
Valeria KoskaDavid Kremer
November 13, 2021

Changes in John Cunningham virus index in Multiple Sclerosis patients treated with different disease-modifying therapies.

Current Neuropharmacology
Eleonora SgarlataFrancesco Patti
November 11, 2021
Case Report

HIV Encephalopathy Mimicking Acute Demyelinating Processes.

Wasey Ali Yadullahi MirLarissa Verda
November 10, 2021

Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy.

Current Opinion in Infectious Diseases
Adam S NelsonEmily Blyth

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved